Copyright Reports & Markets. All rights reserved.

Global Red Biotechnology Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Red Biotechnology Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Gene Recombinant Drugs
      • 1.4.3 Human Vaccines
      • 1.4.4 Blood Products
      • 1.4.5 Diagnostics Reagents
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Red Biotechnology Market Share by Application (2019-2025)
      • 1.5.2 Drug Discovery
      • 1.5.3 Drug Production
      • 1.5.4 Gentic Testing
      • 1.5.5 Pharmacogenomics
      • 1.5.6 Gene Therapy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Red Biotechnology Market Size
    • 2.2 Red Biotechnology Growth Trends by Regions
      • 2.2.1 Red Biotechnology Market Size by Regions (2019-2025)
      • 2.2.2 Red Biotechnology Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Red Biotechnology Market Size by by Players
      • 3.1.1 Global Red Biotechnology Revenue by by Players (2014-2019)
      • 3.1.2 Global Red Biotechnology Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Red Biotechnology Market Concentration Ratio (CR5 and HHI)
    • 3.2 Red Biotechnology Key Players Head office and Area Served
    • 3.3 Key Players Red Biotechnology Product/Solution/Service
    • 3.4 Date of Enter into Red Biotechnology Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Red Biotechnology Market Size by Type (2014-2019)
    • 4.2 Global Red Biotechnology Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Red Biotechnology Market Size (2014-2019)
    • 5.2 Red Biotechnology Key Players in North America
    • 5.3 North America Red Biotechnology Market Size by Type
    • 5.4 North America Red Biotechnology Market Size by Application

    6 Europe

    • 6.1 Europe Red Biotechnology Market Size (2014-2019)
    • 6.2 Red Biotechnology Key Players in Europe
    • 6.3 Europe Red Biotechnology Market Size by Type
    • 6.4 Europe Red Biotechnology Market Size by Application

    7 China

    • 7.1 China Red Biotechnology Market Size (2014-2019)
    • 7.2 Red Biotechnology Key Players in China
    • 7.3 China Red Biotechnology Market Size by Type
    • 7.4 China Red Biotechnology Market Size by Application

    8 Japan

    • 8.1 Japan Red Biotechnology Market Size (2014-2019)
    • 8.2 Red Biotechnology Key Players in Japan
    • 8.3 Japan Red Biotechnology Market Size by Type
    • 8.4 Japan Red Biotechnology Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Red Biotechnology Market Size (2014-2019)
    • 9.2 Red Biotechnology Key Players in Southeast Asia
    • 9.3 Southeast Asia Red Biotechnology Market Size by Type
    • 9.4 Southeast Asia Red Biotechnology Market Size by Application

    10 India

    • 10.1 India Red Biotechnology Market Size (2014-2019)
    • 10.2 Red Biotechnology Key Players in India
    • 10.3 India Red Biotechnology Market Size by Type
    • 10.4 India Red Biotechnology Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Red Biotechnology Market Size (2014-2019)
    • 11.2 Red Biotechnology Key Players in Central & South America
    • 11.3 Central & South America Red Biotechnology Market Size by Type
    • 11.4 Central & South America Red Biotechnology Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen
      • 12.1.1 Amgen Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Red Biotechnology Introduction
      • 12.1.4 Amgen Revenue in Red Biotechnology Business (2014-2019))
      • 12.1.5 Amgen Recent Development
    • 12.2 Beijing Tiantan Biological Products Co.
      • 12.2.1 Beijing Tiantan Biological Products Co. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Red Biotechnology Introduction
      • 12.2.4 Beijing Tiantan Biological Products Co. Revenue in Red Biotechnology Business (2014-2019)
      • 12.2.5 Beijing Tiantan Biological Products Co. Recent Development
    • 12.3 Biogen Idec
      • 12.3.1 Biogen Idec Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Red Biotechnology Introduction
      • 12.3.4 Biogen Idec Revenue in Red Biotechnology Business (2014-2019)
      • 12.3.5 Biogen Idec Recent Development
    • 12.4 Cephalon
      • 12.4.1 Cephalon Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Red Biotechnology Introduction
      • 12.4.4 Cephalon Revenue in Red Biotechnology Business (2014-2019)
      • 12.4.5 Cephalon Recent Development
    • 12.5 Chiron Corporation
      • 12.5.1 Chiron Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Red Biotechnology Introduction
      • 12.5.4 Chiron Corporation Revenue in Red Biotechnology Business (2014-2019)
      • 12.5.5 Chiron Corporation Recent Development
    • 12.6 CSL Limited
      • 12.6.1 CSL Limited Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Red Biotechnology Introduction
      • 12.6.4 CSL Limited Revenue in Red Biotechnology Business (2014-2019)
      • 12.6.5 CSL Limited Recent Development
    • 12.7 Genentech
      • 12.7.1 Genentech Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Red Biotechnology Introduction
      • 12.7.4 Genentech Revenue in Red Biotechnology Business (2014-2019)
      • 12.7.5 Genentech Recent Development
    • 12.8 Genzyme Corporation
      • 12.8.1 Genzyme Corporation Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Red Biotechnology Introduction
      • 12.8.4 Genzyme Corporation Revenue in Red Biotechnology Business (2014-2019)
      • 12.8.5 Genzyme Corporation Recent Development
    • 12.9 Gilead Sciences
      • 12.9.1 Gilead Sciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Red Biotechnology Introduction
      • 12.9.4 Gilead Sciences Revenue in Red Biotechnology Business (2014-2019)
      • 12.9.5 Gilead Sciences Recent Development
    • 12.10 MedImmune LLC
      • 12.10.1 MedImmune LLC Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Red Biotechnology Introduction
      • 12.10.4 MedImmune LLC Revenue in Red Biotechnology Business (2014-2019)
      • 12.10.5 MedImmune LLC Recent Development
    • 12.11 Serono SA
    • 12.12 Shenyang Sunshine Pharmaceutical Co.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Red biotechnology is the application of biotechnology in biopharmaceuticals and pharmaceuticals production. It provides patients with innovative and modern modes of diagnostics and treatments.
      In 2018, the global Red Biotechnology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Red Biotechnology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Red Biotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Amgen
      Beijing Tiantan Biological Products Co.
      Biogen Idec
      Cephalon
      Chiron Corporation
      CSL Limited
      Genentech
      Genzyme Corporation
      Gilead Sciences
      MedImmune LLC
      Serono SA
      Shenyang Sunshine Pharmaceutical Co.

      Market segment by Type, the product can be split into
      Gene Recombinant Drugs
      Human Vaccines
      Blood Products
      Diagnostics Reagents
      Others

      Market segment by Application, split into
      Drug Discovery
      Drug Production
      Gentic Testing
      Pharmacogenomics
      Gene Therapy

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Red Biotechnology status, future forecast, growth opportunity, key market and key players.
      To present the Red Biotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Red Biotechnology are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now